XERS - Our Prognosis On Xeris
"Freedom began on the day the first sheep wandered away from the herd." - Marty Rubin
Today, we look at a small healthcare concern with a familiar business model. The company recently addressed its funding needs, has a potential product approval on the horizon, and is selling near all-time lows.
Company Overview
Xeris Pharmaceuticals (XERS) IPO'd in 2018 and is a Chicago, Illinois-based specialty pharmaceutical company developing ready-to-use, liquid-stable injectables. The company is developing therapeutics by leveraging its proprietary technology platforms, XeriSol and XeriJect. The company's pipeline is broken down into two